Abstract.-The ability of guinea pigs to respond immunologically to dinitrophenyl (DNP)-poly-L-arginine, DNP-protamine, DNP polyornithine, and to unsubstituted poly-L-arginine and protamine is linked to the presence of the poly-L-lysine gene. This gene has previously been demonstrated to control the immune response of guinea pigs to poly-L-lysine, to a copolymer of L-glutamic acid and L-lysine and to haptenic derivatives of these materials.
The ability of guinea pigs to make an immune response to poly-L-lysine (PLL) or to a random copolymer of L-glutamic acid and -lysine (GL) and to hapten conjugates of both PLL and GL is controlled by a single autosomal dominant gene, the PLL gene. [1] [2] [3] [4] The immune response to hapten-PLL conjugates or to hapten-GL conjugates is characterized by the production of large amounts of serum anti-hapten antibody, and by the presence of cellular immunity to the immunizing antigen.1' The latter is manifested both by delayed hyper-sensitivity and by antigenmediated stimulation of DNA synthesis in lymph node cell cultures. 6 Those animals making such an immune response are termed responders and are regarded as possessing the PLL gene. Guinea pigs not displaying these responses are nonresponders and are regarded as lacking the PLL gene.4 All strain 2 guinea pigs and a varying percentage of randomly bred Hartley strain guinea pigs, depending on their origin, are responders whereas all strain 13 guinea pigs are nonresponders to these antigens. 2' 6 In the current study, we demonstrate that the immune response to a series of related compounds is also controlled by the PLL gene. These compounds are hapten (2,4-dinitrophenyl-DNP) conjugates of poly-i-arginine, poly-L-ornithine, and protamine as well as unconjugated poly-L-arginine and protamine. Although the response to each of these highly positively charged compounds is linked to the presence of the PLL gene, the cellular immune responses to these antigens are highly specific and are capable of discriminating between them. Results.-All strain 2 and PLIgene positive Hartley strain guinea pigs, im-munized with PLA, protamine, DNP-PLA, or DNP-protamine made an immune response to these antigens as manifested by delayed sensitivity, and in the case of the DNP conjugates, by the presence of high serum concentrations of anti-DNP antibodies. The immune response of strain 13 and of PLL-gene negative Hartley strain guinea pigs was remarkably different from that of the previous groups. These animals did not develop delayed hypersensitivity to PLA, protamine, or to their DNP conjugates following immunization with these materials regardless of the amount and type of mycobacteria used as adjuvant. Furthermore, anti-DNP antibodies were not detected in the sera of nonresponder animals at two weeks after immunization with DNP-PLA and 2 mg/ml M. tuberculosis. Strain 13 guinea pigs immunized with DNP-protamine and 10 mg/ml of M. tuberculosis developed very low serum levels of anti-DNP antibodies (Table  1) . Thus, immune responses to PLA, protamine, and to DNP conjugates of these molecules appear to be restricted to guinea pigs possessing the PLL gene.
Poly-L-ornithine hydrobromide and DNP-PLO behaved differently. No evidence of sensitivity to PLO could be detected in any guinea pigs regardless of their PLL gene status at any time up to four weeks after immunization with this homopolymer and adjuvant containing either 0.5 mg or 10 mg/ml of mycobacteria; DNP-PLO, however, did stimulate cellular immunity but only in guinea pigs possessing the PLL gene. MIost, but not all, strain 2 and PLE-gene positive Hartley strain guinea pigs developed delayed sensitivity to this conjugate. It is of interest that the strongest reactions to DNP-PLO were elicited in guinea pigs immunized with 0.5 mg/ml M. butyricum but that anti-DNP antibodies were not detected in the sera of these animals. Strain 13 and PLL-gene negative Hartley strain guinea pigs did not develop delayed sensitivity to DNP-PLO or anti-DNP antibodies when immunized with adjuvant containing 0.5 mg/ml of mycobacteria. When larger amounts of mycobacteria were used, both PLLgene positive and PLE-gene negative animals produced anti-DNP antibodies (Table 1 ). This ability of strain 13 and Hartley nonresponder guinea pigs to produce anti-DNP antibody without evidence of delayed sensitivity when immunized with DNP-PLO and large amounts of M. tuberculosis might be explained in part by the observation that mycobacteria can act in a manner similar to immunogenic foreign albumins,9 as "schleppers" or "immunogenic carriers" for these positively charged antigens.5
Since the ability to form immune responses to several structurally related positively charged antigens has been shown to be genetically linked, it seemed relevant to investigate the specificities of the cellular immune responses to these materials. Tables 2 and 3 present, respectively, data concerning the ability of several of these antigens to elicit delayed hypersensitivity in guinea pigs immunized with one of these antigens and to stimulate DNA synthesis in lymph node cell cultures from such animals. Both of these phenomena display a high degree of specificity for the immunizing antigen, although cross reactions were observed to some of the related compounds.
Discussion.-The responsiveness of guinea pigs to PLA, DNP-PLA, protamine, DNP-protamine and DNP-PLO, a family of antigens characterized by their content of positively charged L-amino acids, is linked to their ability to individual animals, in which antigen is added to such radioactivity in identical cultures to which no antigen is added. A value of this ratio significantly greater than one indicates stimulation of DNA synthesis. When DNP-PLL at 0.01 mg/ml is utilized, ratios greater than 1.5 are considered significant as control cultures from guinea pigs immunized with adjuvant-saline emulsions yielded ratios ranging from 0.7 to 1.4 when exposed to this antigen at this concentration.
respond to GL and thus to the presence of a dominant autosomal gene which has been shown to control the response of guinea pigs to PLL, GL, and hapten conjugates of these polypeptides. [1] [2] [3] [4] Earlier studies on the site of adtion of the PLL gene suggested that the gene controls an interaction with L-lysine peptides4' 6, 9 with at least 8 residues.'1 The present data indicates that the PLL gene product can interact as well with L-arginine peptides and L-ornithine peptides to which DNP has been conjugated.
Despite this genetic linkage, the cellular immune response to these substances are highly specific and readily discriminate between these antigens. It has previously been established that the antibody responses to GL and DNP-PLL display the range of class and affinity heterogeneity usually observed in induced antibodies." 112 Thus, either a single gene or a series of closely linked genes controls the immune response to a group of structurally related, but distinct substances. The operation of this genetic factor, nevertheless, permits highly specific and diverse immune responses. These findings make it improbable that the PLL gene is concerned with the sequence of the variable segment of immunoglobulin chains and suggest the existence 6f another level of specific interaction required for these antigens to induce A Specific immune response. In recent years several systems have been showt to be similarly under the control of autosomal dominant genetic factors,'2-'6 not linked with immunoglobulin allotypes.3-'5 It must, therefore, be considered that genes controlling specific interactions at levels other than imtnunoglobulins may be essential to specific immune responses.
A comparison of the immunogenicity of the antigens, the response to which is under control of the PLL gene reveals that PLL, PLA, protamine, and. their DNP conjugates are strong antigens, but that PLO does not induce specific hypersensitivity and that DNP-PLO is a very weak immunogen. This difference parallels the relative susceptibility of these polymers to act as substrates for trypsin. 17 Two other findings deserve further comment. The demonstration that protamine, a naturally occurring polypeptide, is immunogenic in guinea pigs possessing the PLL gene is of considerable interest in view of the wide clinical use of this agent. Previous studies18-20 of the immunogenicity of protamine in animals, with but one exception,2' have indicated that this substance does not evoke an immune response. Although protamine has been administered to humans for many years no unequivocal evidence of allergic reactions to protamine has been presented.22 Finally, the effect of the dose of mycobacterial adjuvant on the response to a weak immunogen such as DNP-PLO is of general interest. The intensity of delayed sensitivity reactions to DNP-PLO in PLL-gene positive guinea pigs was considerably decreased by the use of large amounts of mycobacteria. In contrast, the use of large amounts of mycobacteria with DNP-PLO stimulated the synthesis of anti-DNP antibodies by both responder and nonresponder guinea pigs by a process where the mycobacteria may have acted as an immunogenic "schlepper" for the positively charged polymer., 9 This type of response has also been observed following immunization of guinea pigs with DNP oligo-iAysine peptides,23 or with DNP-poly--lysine and high amounts of mycobacteria.24
